North America Continuous Glucose Monitoring Market Report and Forecast 2025-2034

The North America continuous glucose monitoring market was valued at USD 6.56 Billion in 2024, driven by the rising cases of diabetes and new product launches in the region. The market is further projected to grow at a CAGR of 14.50% between 2025 and 2034, reaching a value of USD 25.41 Billion by 2034 .

North America Continuous Glucose Monitoring Market Overview

Continuous glucose monitoring (CGM) refers to using a device that helps to automatically measure the blood glucose level throughout the day and night. The device generally consists of three parts: a tiny sensor that estimates the glucose level in the blood, a transmitter that sends the information, and a receiver that displays the data. The rising cases of diabetes in North American countries are driving the growth of the market. Further, the increasing advancements in CGM technology such as better accuracy, longer sensor wear times, and integration with digital platforms are anticipated to elevate the market value. Moreover, the presence of a positive regulatory environment and the rising healthcare expenditure are some of the factors expected to influence the market dynamics.

North America Continuous Glucose Monitoring Market Growth Drivers

Rising Cases of Diabetes Drives Market Growth

Type 2 diabetes constitutes nearly 95% of all diabetes cases (both diagnosed and undiagnosed) in the United States. The rising burden of diabetes is a primary driver of the market. The increasing number of diagnosed cases of diabetes is leading to a higher demand for effective glucose management solutions such as continuous glucose monitoring (CGM) devices. However, about 70% of continuous glucose monitor (CGM) usage is by individuals with type 1 diabetes (T1D), with only 3-4% of the US population with type 2 diabetes (T2D) using CGM despite its proven advantages. Further, improvements in device technology, reimbursement policies, and digital health strategies aimed at enhancing health awareness and motivation are anticipated to stimulate market growth.

North America Continuous Glucose Monitoring Market Trends

The market is witnessing several trends and developments to improve the current scenario in North America. Some of the notable trends are as follows:

Regulatory Approval of Innovative Continuous Glucose Monitoring Devices to Affect the Market Landscape Significantly

In March 2024, the US Food and Drug Administration cleared the first over-the-counter continuous glucose monitoring system in the United States: The Dexcom Stelo Glucose Biosensor System. The “Stelo Glucose Biosensor System” employs a wearable sensor that, when synced with an app on the user’s smartphone or another smart device, continuously monitors, records, analyses, and displays glucose levels for individuals aged 18 and above. It is designed for those not using insulin and without issues related to low blood sugar (hypoglycemia). The rise in regulatory approval of such innovative continuous glucose monitoring systems is poised to fuel market growth.

New Product Launches to Augment North America Continuous Glucose Monitoring Market Demand

In April 2023, a new reader device for Abott’s FreeStyle Libre® 3 integrated continuous glucose monitoring (iCGM) system, the latest addition to the FreeStyle Libre product line, received clearance from the US Food and Drug Administration (FDA). The novel reader, which works with the world’s thinnest, smallest, and most discreet glucose sensor, is a small handheld device that allows viewing of real-time glucose readings on an easy-to-see screen. The surge in the launch of new continuous glucose monitoring products by the key market players is anticipated to augment the market demand.

Advancements in Sensor Technologies to Elevate the North America Continuous Glucose Monitoring Market Value

The market is experiencing a growing demand for non-invasive and minimally invasive sensor technologies as these devices help reduce discomfort and improve user compliance. For instance, in February 2024, Know Labs, Inc. announced the development of a wearable, non-invasive continuous glucose monitor (CGM) called the KnowU device, which is integrated with a sensor that can detect glucose levels through spectroscopy. Such advances in sensor technology are anticipated to elevate the market value in the forecast period.

Growing Adoption of CGM Devices in Pediatric Patients to Boost North America Continuous Glucose Monitoring Market Size

One of the major market trends is the rise in the adoption of continuous glucose monitoring systems in pediatric populations. The increasing introduction of advanced CGM systems specially designed for children further supports this trend. Such devices are often integrated with smaller, more comfortable sensors and user-friendly interfaces, making it easier for children to wear and use the devices.

North America Continuous Glucose Monitoring Market Segmentation

North America Continuous Glucose Monitoring Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Components

• Sensors
• Transmitters
• Receivers

Market Breakup by Application

• Type 1 Diabetes
• Type 2 Diabetes
• Others

Market Breakup by Age Group

• Adult Population
• Child Population

Market Breakup by End User

• Hospitals & Clinics
• Home Healthcare
• Others

Market Breakup by Country

• United States of America
• Canada

North America Continuous Glucose Monitoring Market Share

Market Segmentation Based on End User is Anticipated to Witness Substantial Growth

Based on the end user, the market is segmented into hospitals and clinics, home healthcare, and others. Home healthcare represents a rapidly growing segment within the market driven by the rising shift towards home-based care solutions for managing chronic conditions like diabetes. Besides being cost-effective, CGM systems allow patients to monitor their glucose levels from the comfort of their homes without the need for frequent hospital visits. Further, the increasing aging population in North America suffering from diabetes is likely to fuel the demand for this segment.

North America Continuous Glucose Monitoring Market Analysis by Region

The market is segmented by country into the United States of America and Canada. The United States dominates the market share owing to the high prevalence of diabetes and a well-established healthcare system. The presence of a supportive regulatory framework, led by the United States FDA, further supports growth and innovation in the market. Moreover, a heightened awareness of the benefits of continuous glucose monitoring among both healthcare providers and patients is projected to aid market expansion in the forecast period.

Leading Players in the North America Continuous Glucose Monitoring Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

Abbott

This American multinational medical devices and health care company is headquartered in Illinois, United States. Abbott's FreeStyle Libre 2 represents the only integrated continuous glucose monitoring (iCGM) system for adults and children (aged 4 years and above) in the United States that offers optional real-time alarms along with unsurpassed 14-day accuracy.

Dexcom, Inc.

California-based Dexcom, Inc. specializes in the development, manufacturing, and distribution of continuous glucose monitoring (CGM) systems for diabetes management. Dexcom's CGM product line features smaller sensors with connectivity options.

Medtronic PLC

American-Irish medical device company, Medtronic PLC, is a prominent player in the market. The company is focused on integrating its CGM systems with insulin pumps to provide convenient diabetes management solutions.

Senseonics, Inc

Senseonics, Inc., headquartered in Maryland, United States, is a medical device startup company recognized for its innovative glucose monitoring products. The company heavily invests in research and development to improve the longevity and accuracy of its implantable sensors.

Other key players in the market include Byram Healthcare Centers, Inc. and Hoffmann-La Roche Limited.

Key Questions Answered in the North America Continuous Glucose Monitoring Market Report

• What was the North America continuous glucose monitoring market value in 2024?
• What is the North America continuous glucose monitoring market forecast outlook for 2025-2034?
• What are the regional markets covered in the report?
• What is market segmentation based on components?
• What is the market breakup based on application?
• What is the market breakup by age group?
• Who are the major end users in the market?
• What are the major factors aiding the North America continuous glucose monitoring market demand?
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• Which regional market is expected to lead the market share in the forecast period?
• Which country is expected to experience expedited growth during the forecast period?
• How does the prevalence and incidence of diabetes affect the market landscape?
• What are the major North America continuous glucose monitoring market trends?
• How do the advances in continuous glucose monitoring technology impact the market size?
• Which components will dominate the market share?
• Which application is expected to have a high market value in the coming years?
• Which age group will experience the highest demand in the market segment?
• Which end user is projected to contribute to the highest market growth?
• Who are the key players involved in the North America continuous glucose monitoring market?
• What is the patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.